PRESS RELEASE published on 11/14/2024 at 14:59, 9 days ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.91% interest in Smith (DS) plc. Additional disclosures include dealings with Smith (DS) plc's securities Securities Dealings Takeover Code Vanguard Group Ownership Disclosure Smith DS Plc
PRESS RELEASE published on 11/14/2024 at 14:58, 9 days ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses a 5.21% interest in Spirent Communications plc. Form 8.3 filing as per Takeover Code Form 8.3 Disclosure The Vanguard Group Takeover Code Spirent Communications PLC
BRIEF published on 11/13/2024 at 15:32, 9 days 23 hours ago Vanguard Group Discloses Position in International Paper Company Form 8.3 Takeover Code Securities Disclosure Vanguard Group International Paper
BRIEF published on 11/13/2024 at 15:30, 9 days 23 hours ago The Vanguard Group Discloses Position in AngloGold Ashanti plc Form 8.3 The Vanguard Group Takeover Code Shareholding Disclosure AngloGold Ashanti
BRIEF published on 11/13/2024 at 15:27, 9 days 23 hours ago The Vanguard Group Discloses Interests in SEGRO plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group SEGRO PLC
PRESS RELEASE published on 11/13/2024 at 15:27, 9 days 23 hours ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses a 11.79% interest in International Paper Company as of 12th November 2024 Vanguard Group Financial Interest Stock Disclosure International Paper Company Rule 8.3 Disclosure
BRIEF published on 11/13/2024 at 15:25, 9 days 23 hours ago The Vanguard Group Discloses Stake in Hargreaves Lansdown Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Hargreaves Lansdown
PRESS RELEASE published on 11/13/2024 at 15:25, 10 days ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses 4.07% ownership in AngloGold Ashanti plc with 17,104,631 USD 1 ordinary shares. Dealing disclosure as of 12 Nov 2024 The Vanguard Group, Inc. Financial Dealings Ownership Disclosure Stock Positions AngloGold Ashanti Plc
BRIEF published on 11/13/2024 at 15:22, 10 days ago The Vanguard Group Discloses 4.91% Stake in Smith (DS) plc Takeover Code Securities Disclosure Vanguard Group Share Transactions Smith DS
PRESS RELEASE published on 11/13/2024 at 15:22, 10 days ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.16% interest in SEGRO plc's 10p ordinary securities. Recent transactions include purchases and sales The Vanguard Group 10p Ordinary Securities Interest Disclosure Recent Transactions SEGRO PLC
Published on 11/22/2024 at 23:55, 15 hours 30 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 15 hours 55 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 16 hours 20 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 16 hours 55 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 21 hours 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 21 hours 32 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 22 hours 30 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 23 hours 25 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 8 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 20 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 21 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
